IASO-782 in Systemic Lupus Erythematosus

Clinical trial NCT07483346 · RECRUITING

Trial details

NCT number: NCT07483346
Sponsor: Shanghai IASO Biotechnology Co., Ltd
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

SLE - Systemic Lupus Erythematosus

Start date: 2026-05-26
Primary completion: 2027-08-31
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.